These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28285962)

  • 1. The ERK/MAPK pathway is overexpressed and activated in gallbladder cancer.
    Buchegger K; Silva R; López J; Ili C; Araya JC; Leal P; Brebi P; Riquelme I; Roa JC
    Pathol Res Pract; 2017 May; 213(5):476-482. PubMed ID: 28285962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
    Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y
    J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR7 mediates the TNF-α-induced lymphatic metastasis of gallbladder cancer through the "ERK1/2 - AP-1" and "JNK - AP-1" pathways.
    Hong H; He C; Zhu S; Zhang Y; Wang X; She F; Chen Y
    J Exp Clin Cancer Res; 2016 Mar; 35():51. PubMed ID: 27009073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant activation of Sonic hedgehog signaling in chronic cholecystitis and gallbladder carcinoma.
    Xie F; Xu X; Xu A; Liu C; Liang F; Xue M; Bai L
    Hum Pathol; 2014 Mar; 45(3):513-21. PubMed ID: 24440094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of phospho-ERK1/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations.
    Li Q; Yang Z
    J Exp Clin Cancer Res; 2009 May; 28(1):65. PubMed ID: 19445727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1/2/AP-1/VEGF-D pathway.
    Hong H; Jiang L; Lin Y; He C; Zhu G; Du Q; Wang X; She F; Chen Y
    BMC Cancer; 2016 Mar; 16():240. PubMed ID: 26992854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing.
    Li M; Chen L; Qu Y; Sui F; Yang Q; Ji M; Shi B; Chen M; Hou P
    Oncotarget; 2017 May; 8(22):36319-36330. PubMed ID: 28422736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway.
    Liu ZY; Cao J; Zhang JT; Xu GL; Li XP; Wang FT; Ansari KH; Mohamed H; Fan YZ
    Oncotarget; 2017 Jul; 8(30):49897-49914. PubMed ID: 28611292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibronectin promotes cell proliferation and invasion through mTOR signaling pathway activation in gallbladder cancer.
    Cao Y; Liu X; Lu W; Chen Y; Wu X; Li M; Wang XA; Zhang F; Jiang L; Zhang Y; Hu Y; Xiang S; Shu Y; Bao R; Li H; Wu W; Weng H; Yen Y; Liu Y
    Cancer Lett; 2015 May; 360(2):141-50. PubMed ID: 25657110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connective tissue growth factor immunohistochemical expression is associated with gallbladder cancer progression.
    Garcia P; Leal P; Alvarez H; Brebi P; Ili C; Tapia O; Roa JC
    Arch Pathol Lab Med; 2013 Feb; 137(2):245-50. PubMed ID: 23368866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway.
    Wu XS; Wang XA; Wu WG; Hu YP; Li ML; Ding Q; Weng H; Shu YJ; Liu TY; Jiang L; Cao Y; Bao RF; Mu JS; Tan ZJ; Tao F; Liu YB
    Cancer Biol Ther; 2014 Jun; 15(6):806-14. PubMed ID: 24658096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway.
    Shen H; He M; Lin R; Zhan M; Xu S; Huang X; Xu C; Chen W; Yao Y; Mohan M; Wang J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):247. PubMed ID: 31182136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Artemisinin inhibits proliferation of gallbladder cancer cell lines through triggering cell cycle arrest and apoptosis].
    Jia JG; Zhang LG; Guo CX; Wang YG; Chen BL; Wang YM; Qian J
    Zhonghua Wai Ke Za Zhi; 2016 Mar; 54(3):222-7. PubMed ID: 26932893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of hsa‑miR‑372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1.
    Zhou N; Cheng W; Peng C; Liu Y; Jiang B
    Mol Med Rep; 2017 Nov; 16(5):7848-7854. PubMed ID: 28944858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and deregulations in base excision repair pathway as contributors to gallbladder anomalies and carcinoma - a study involving North-East Indian population.
    Singh N; Kazim SN; Sultana R; Tiwari D; Borkotoky R; Kakati S; Nath Das N; Kumar Saikia A; Bose S
    Free Radic Res; 2019 May; 53(5):473-485. PubMed ID: 31117842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks.
    Mohri D; Ijichi H; Miyabayashi K; Takahashi R; Kudo Y; Sasaki T; Asaoka Y; Tanaka Y; Ikenoue T; Tateishi K; Tada M; Isayama H; Koike K
    J Gastroenterol; 2016 Jul; 51(7):711-21. PubMed ID: 26614007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen-related receptor-α promotes gallbladder cancer development by enhancing the transcription of Nectin-4.
    Wang L; Yang M; Guo X; Yang Z; Liu S; Ji Y; Jin H
    Cancer Sci; 2020 May; 111(5):1514-1527. PubMed ID: 32030850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of ERK1/2 MAPK signaling transduction pathway in esophageal cancers in Kazakh patients].
    Zheng ST; Liu T; Middottuersun A; Huo Q; Liu Q; Huang CG; Feng JG; Lü GD; Wang X; Lin RY; Sheyhidin I; Lu XM
    Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):421-5. PubMed ID: 21875481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis.
    Qin Y; Chu B; Gong W; Wang J; Tang Z; Shen J; Quan Z
    J Gastroenterol Hepatol; 2014 May; 29(5):964-72. PubMed ID: 24329682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4.
    Niu J; Li Z; Li F
    Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G670-G681. PubMed ID: 31369289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.